AI assistant
Sending…
PRECIGEN, INC. — Director's Dealing 2017
Oct 17, 2017
32044_dirs_2017-10-17_366a2e6f-d2e0-40b0-ae0f-0b9c23cb9bc6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: INTREXON CORP (XON)
CIK: 0001356090
Period of Report: 2017-10-16
Reporting Person: Reed Thomas D. (Chief Science Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-10-16 | Common Stock | M | 29692 | $2.64 | Acquired | 93809 | Direct |
| 2017-10-16 | Common Stock | M | 8906 | $2.64 | Acquired | 102715 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-10-16 | Option to Purchase Common Stock (Right to Buy) | $2.64 | M | 29692 | Disposed | 2017-11-15 | Common Stock (29692) | Direct |
| 2017-10-16 | Option to Purchase Common Stock (Right to Buy) | $2.64 | M | 8906 | Disposed | 2018-02-20 | Common Stock (8906) | Direct |
Footnotes
F1: The option was immediately exercisable.
More from PRECIGEN, INC.
Regulatory Filings
2026
May 13
Annual Report
2026
Apr 30
Director's Dealing
2026
Mar 21
Director's Dealing
2026
Mar 21
Director's Dealing
2026
Mar 21
Director's Dealing
2026
Mar 21
Director's Dealing
2026
Mar 21
Major Shareholding Notification
2026
Feb 13
Major Shareholding Notification
2026
Jan 23
Director's Dealing
2025
Dec 23